127 related articles for article (PubMed ID: 30827803)
1. Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score.
Dupré A; Berhane S; Chan AWH; Rivoire M; Chong CCN; Lai PBS; Cucchetti A; Poston GJ; Malik HZ; Johnson PJ
Eur J Surg Oncol; 2019 Jun; 45(6):999-1004. PubMed ID: 30827803
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
3. Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
Dupré A; Malik HZ; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ
Eur J Surg Oncol; 2018 Jan; 44(1):80-86. PubMed ID: 29183640
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
5. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
[TBL] [Abstract][Full Text] [Related]
6. Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
Dupré A; Rehman A; Jones RP; Parker A; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
J Surg Oncol; 2018 May; 117(6):1330-1336. PubMed ID: 29315600
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
[No Abstract] [Full Text] [Related]
8. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
9. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
[TBL] [Abstract][Full Text] [Related]
10. Larger hepatic metastases are more frequent with N0 colorectal tumours and are associated with poor prognosis: implications for surveillance.
Partelli S; Mukherjee S; Mawire K; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
Int J Surg; 2010; 8(6):453-7. PubMed ID: 20601252
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
12. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Brudvik KW; Jones RP; Giuliante F; Shindoh J; Passot G; Chung MH; Song J; Li L; Dagenborg VJ; Fretland ÅA; Røsok B; De Rose AM; Ardito F; Edwin B; Panettieri E; Larocca LM; Yamashita S; Conrad C; Aloia TA; Poston GJ; Bjørnbeth BA; Vauthey JN
Ann Surg; 2019 Jan; 269(1):120-126. PubMed ID: 28549012
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases.
Neal CP; Mann CD; Sutton CD; Garcea G; Ong SL; Steward WP; Dennison AR; Berry DP
Eur J Cancer; 2009 Jan; 45(1):56-64. PubMed ID: 18848775
[TBL] [Abstract][Full Text] [Related]
17. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
[TBL] [Abstract][Full Text] [Related]
18. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
[TBL] [Abstract][Full Text] [Related]
19. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
Zeman M; Maciejewski A; Półtorak S; Kryj M
Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
